Surgery Partners (SGRY) Earnings Analysis

Surgery Partners (SGRY) has no confirmed upcoming earnings date. Last quarter (2026-03-02) it missed with EPS 0.12 USD vs 0.31 USD est (-61.3%). It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E -25.69.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does SGRY next report earnings?

No confirmed upcoming earnings date is currently scheduled for SGRY. This page updates as the calendar is published.

SGRY earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-020.12 USD0.31 USD-61.3%Miss
2025-11-100.13 USD0.19 USD-31.6%Miss
2025-05-120.04 USD0.08 USD-50%Miss
2025-03-030.44 USD0.38 USD+15.8%Beat

Beat rate: 1/4 (25%) over reported quarters with consensus data.

SGRY valuation and analyst view

Trailing P/E-25.69
Trailing EPS-0.59283 USD
Price / book1.15
Dividend yield0.00%
Market cap2.05B
Analyst consensusBuy (14 buy / 8 hold / 0 sell)
Avg price target17 USD

Related research pages

Frequently asked questions

When is Surgery Partners (SGRY)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for SGRY. This page updates as the calendar is published.

Did SGRY beat earnings last quarter?

In its 2026-03-02 report, SGRY posted EPS of 0.12 USD versus a 0.31 USD estimate — a miss of 61.3%.

What is SGRY's earnings track record?

Over the last 4 reported quarters with consensus data, SGRY beat estimates 1 times (25%).

What is SGRY's current P/E ratio and EPS?

SGRY trades at a trailing P/E of -25.69 on trailing EPS of -0.5928314909595145 USD.

What do analysts rate SGRY?

Analyst consensus is "Buy" across 22 ratings (0 strong buy, 14 buy, 8 hold, 0 sell, 0 strong sell). Average 12-month price target: 17 USD.